Advertisement
Advertisement

ELVN

ELVN logo

Enliven Therapeutics, Inc. Common Stock

48.11
USD
Sponsored
+2.77
+6.11%
Apr 17, 16:00 UTC -4
Closed
exchange

After-Market

48.55

+0.44
+0.91%

Enliven Therapeutics, Inc. Common Stock Profile

About

Enliven Therapeutics Inc. is a clinical-stage precision oncology company focused on the discovery and development of small molecule kinase inhibitors. The Company's lead product candidate includes ELVN-001 and ELVN-002. Enliven Therapeutics Inc., formerly known as Imara Inc., is based in Boulder, CO.

Info & Links

CEO

Richard Fair

Headquarters

6200 Lookout Road
Boulder, CO 80301, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.enliventherapeutics.com

Auditor

Deloitte & Touche LLP

Share holders

16

Employees

60

Enliven Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

2.90B

Enterprise Value

2.80B

Enterprise Value/EBITDA(ttm)

-23.44

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

5.89

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-24.22%

Return on Invested Capital(ttm)

-25.77%

Return on Assets(ttm)

-23.39%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-119.62M

Net Income Available to Common(ttm)

-103.69M

Diluted EPS(ttm)

-1.86

Share Statistics

Beta (5Y Monthly)

0.26

52-Week Change

191.05%

S&P 500 52-Week Change

38.15%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

59.80M

Dividend Yield

0.00%

Float4

44.31M

% Held by Insiders

25.90%

% Held by Institutions

95.08%

Balance Sheet

Total Cash(mrq)

462.62M

Total Cash Per Share(mrq)

7.74

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

28.66%

Quick Ratio(mrq)

28.66%

Book Value Per Share(mrq)

7.73

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.24

Free Cash Flow(ytd)

-70.25M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement